Hostname: page-component-78c5997874-j824f Total loading time: 0 Render date: 2024-11-09T06:09:27.576Z Has data issue: false hasContentIssue false
  • English
  • Français

Ethical Implications of Physician Involvement in Lawsuits on Behalf of the Tobacco Industry

Published online by Cambridge University Press:  01 January 2021

Jess Alderman
Get access Rights & Permissions [Opens in a new window]

Extract

Physicians have long served as expert witnesses in litigation, and their medical knowledge can contribute to the appropriate resolution of a case. However, ethical issues may arise when physicians appear on behalf of the tobacco industry. Two ways that doctors participate in lawsuits are through depositions (statements given under oath before trial to attorneys, who often use them to prepare the case or develop a strategy) and by testifying in court during trial. The Tobacco Deposition and Trial Testimony Archive (DATTA) is an electronic database of depositions, trial testimony, opening and closing statements, and other material from tobacco lawsuits collected by the Center for Tobacco Use Prevention and Research. At the time the research for this article was conducted, the database included depositions and trial testimony of expert witnesses from 232 smoking and health cases.

Type
Independent
Information
Journal of Law, Medicine & Ethics , Volume 35 , Issue 4 , Winter 2007 , pp. 692 - 698
Copyright
Copyright © American Society of Law, Medicine and Ethics 2007

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Deposition of Dr. R. W. Arrington in Texas v. American Tobacco Co. on July 22, 1997, available at <http://tobaccodocuments.org/datta/ARRINGTONR072297.html> (last visited May 16, 2007; password protected).+(last+visited+May+16,+2007;+password+protected).>Google Scholar
Id.Google Scholar
Trial testimony of Dr. S. Barsky in Vandenburg v. Brown & Williamson Tobacco Corp. on February 1, 2006, available at <http://tobacco.neu.edu/litigation/cases/supportdocs/barsky_vandenburg_v_bw.pdf> (last visited September 26, 2007).+(last+visited+September+26,+2007).>Google Scholar
Id.Google Scholar
Trial testimony of Dr. M. Manyak in Allen v. R. J. Reynolds Tobacco Co. on February 25, 2003, available at <http://tobaccodocuments.org/datta/MANYAKM022503.html> (last visited May 16, 2007; password protected).+(last+visited+May+16,+2007;+password+protected).>Google Scholar
Id.Google Scholar
Nelson, H. H. Kelsey, K. T., “The Molecular Epidemiology of Asbestos and Tobacco in Lung Cancer,” Oncogene 21, no. 48 (2002): 7284–88.CrossRefGoogle Scholar
U.S. Department of Health and Human Services, Reducing the Health Consequences of Smoking: 25 Years of Progress, A Report of the Surgeon General, DHHS Publication No. (CDC) 89–8411 (1989), at 43, available at <http://profiles.nlm.nih.gov/NN/B/B/X/S/_/nnbbxs.pdf> (last visited September 26, 2007).+(last+visited+September+26,+2007).>Google Scholar
Id., at 97.Google Scholar
Daubert v. Merrell Dow Pharmaceuticals Inc., 509 U.S. 579 (1993).Google Scholar
Daubert v. Merrell Dow Pharmaceuticals Inc., 43 F.3d 1311 (9th Cir. 1995).Google Scholar
Givelber, D. Strickler, L., “Junking Good Science: Undoing Daubert v. Merrill [sic] Dow Through Cross-Examination and Argument,” American Journal of Public Health 96, no. 1 (2006): 33–7.CrossRefGoogle Scholar
Id.Google Scholar
Id.Google Scholar
Id.Google Scholar
Id.Google Scholar
Trial testimony of Dr. A. M. Martin, Jr., in Covert v. Liggett Group Inc. on January 24, 1994, Bates: 85878617–85878815, available at <http://tobaccodocuments.org/datta/MARTINA012494.html> (last visited May 16, 2007; password protected).+(last+visited+May+16,+2007;+password+protected).>Google Scholar
Id.Google Scholar
Trial testimony of Dr. G. T. Hensley in Engle v. R. J. Reynolds Tobacco Corp. on March 30, 1999, available at <http://tobaccodocuments.org/datta/HENSLEYG033099PM.html> (last visited May 16, 2007; password protected).+(last+visited+May+16,+2007;+password+protected).>Google Scholar
Id.Google Scholar
Id.Google Scholar
Trial testimony of Dr. L. Villa in Routh v. Philip Morris Inc. on October 3, 2003, available at <http://tobaccodocuments.org/datta/VILLAL100303AM.html> (last visited May 16, 2007; password protected) and <http://tobaccodocuments.org/datta/VILLAL100303PM.html> (last visited May 16, 2007; password protected).+(last+visited+May+16,+2007;+password+protected)+and++(last+visited+May+16,+2007;+password+protected).>Google Scholar
Id.Google Scholar
Id.Google Scholar
Id.Google Scholar
Id.Google Scholar
Id.Google Scholar
Id.Google Scholar
Id.Google Scholar
Id.Google Scholar
Id.Google Scholar
Id.Google Scholar
See trial testimony of Dr. Martin in Covert, supra note 17.Google Scholar
Deposition of Dr. A. M. Martin in Gilboy v. American Tobacco Co. on April 28, 1993, available at <http://tobaccodocuments.org/datta/MARTINA042893.html> (last visited May 16, 2007; password protected).+(last+visited+May+16,+2007;+password+protected).>Google Scholar
Trial testimony of Dr.Chediak, A. D. in Routh v. Philip Morris Inc. on October 8, 2003, available at <http://tobaccodocuments.org/datta/CHEDIAKA100803AM.html> (last visited May 16, 2007; password protected).+(last+visited+May+16,+2007;+password+protected).>Google Scholar
See Trial testimony of Dr.Manyak, in Allen, supra note 5.Google Scholar
Deposition of Dr. W. Rymer in Engle v. R. J. Reynolds Tobacco Co. on January 7, 1998, Bates: 517218481 – 517218537, available at <http://tobaccodocuments.org/datta/RYMERW010798.html> (last visited May 16, 2007; password protected).+(last+visited+May+16,+2007;+password+protected).>Google Scholar
See Deposition of Dr. Arrington in Texas v. American Tobacco Co., supra note 1.Google Scholar
Id.Google Scholar
American College of Preventive Medicine, “Resolution X (I− 01): ‘Expert’ Witness Testimony by Physicians on Behalf of Tobacco Companies,” available at <http://www.acpm.org/pol_comp2001–071(D).htm> (last visited September 26, 2007).+(last+visited+September+26,+2007).>Google Scholar
American Medical Association, “Policy H-265.994: Expert Witness Testimony,” available at <http://www.ama-assn.org/apps/pf_new/pf_online?f_n=browse&n_p=T&&s_t=&st_p=&nth=1&prev_pol=policyfiles/HnE/H-265.992.HTM&nxt_pol=policyfiles/HnE/H-265.994.HTM&> (last visited September 26, 2007).+(last+visited+September+26,+2007).>Google Scholar
American Medical Association, “Policy E-9.07: Medical Testimony,” available at <http://www.ama-assn.org/ama/pub/category/8539.html> (last visited September 26, 2007).+(last+visited+September+26,+2007).>Google Scholar
See AMA, Policy H-265.994, supra note 41.Google Scholar
Albert, T., “AMA Aims Lie Detector at Tobacco Testimony,” AMNews, July 7, 2003, available at <http://www.tobacco.org/news/130930.html?top_only=1> (last visited September 26, 2007).Google Scholar
Id.Google Scholar
Id.Google Scholar